Related Experiment Video
Updated: Sep 25, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Lysosome-Instructed Self-Assembly of Amino-Acid-Functionalized Perylene Diimide for Multidrug-Resistant Cancer Cells
Changjoon Keum1, Jiyoung Hong2, Doyeon Kim2
1Department of Chemical and Biomolecular Engineering, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
Abstract:
Multidrug resistance (MDR) of cancer cells reduces chemotherapeutic efficacy by preventing drug accumulation in the cells through a drug efflux pump and lysosomal sequestration/exocytosis. Herein, to overcome such anticancer resistance, lysosome-targeted self-assembly of perylene diimide (PDI) derivatives is presented as a powerful strategy for effective and selective anticancer therapy. Stimulated by the lysosomal low pH, the amphiphilic PDI derivatives functionalized with amino acids (PDI-AAs) construct fibrous self-assembled structures inside the lysosomes, causing cancer cell apoptosis by lysosomal rupture. In contrast, negligible apoptosis was observed from normal cells by PDI-AA. The agglomerated fibrous assemblies were not removed by lysosomal exocytosis, thereby displaying a 10.7-fold higher anticancer efficacy on MDR cancer cells compared to a doxorubicin chemotherapeutic agent. The MDR-circumventing capability, along with high selectivity toward cancer cells, supports PDI-AAs as potential candidates for the treatment of MDR cancer cells by lysosome-targeted self-assembly.
Insights
This study presents perylene diimide derivatives (PDI-AAs) that self-assemble in lysosomes to overcome multidrug resistance (MDR) in cancer cells. This targeted approach enhances anticancer efficacy and selectivity against MDR cancer cells.
Area of Science:
- Biochemistry
- Materials Science
- Oncology
Background:
- Multidrug resistance (MDR) in cancer cells significantly limits chemotherapy effectiveness.
- Drug efflux pumps and lysosomal sequestration/exocytosis mechanisms contribute to MDR.
- Novel strategies are needed to circumvent MDR and improve therapeutic outcomes.
Purpose of the Study:
- To develop a lysosome-targeted self-assembly strategy using perylene diimide (PDI) derivatives to overcome anticancer drug resistance.
- To investigate the mechanism of PDI derivatives in inducing apoptosis in MDR cancer cells.
- To evaluate the efficacy and selectivity of PDI derivatives compared to conventional chemotherapy.
Main Methods:
- Synthesis of amphiphilic perylene diimide derivatives functionalized with amino acids (PDI-AAs).
- Investigation of pH-stimulated self-assembly of PDI-AAs within lysosomes.
- Assessment of lysosomal rupture and cancer cell apoptosis induction.
- Comparative efficacy studies on multidrug-resistant (MDR) cancer cells versus normal cells and doxorubicin treatment.
Main Results:
- PDI-AAs self-assembled into fibrous structures within lysosomes, triggered by low pH.
- Lysosomal rupture and apoptosis were induced in MDR cancer cells.
- Normal cells showed negligible apoptosis, indicating high selectivity.
- PDI-AAs demonstrated a 10.7-fold higher anticancer efficacy against MDR cancer cells compared to doxorubicin.
- Agglomerated PDI-AA assemblies were resistant to lysosomal exocytosis.
Conclusions:
- Lysosome-targeted self-assembly of PDI-AAs offers a potent strategy to overcome MDR in cancer.
- PDI-AAs exhibit significant anticancer efficacy and selectivity, making them promising candidates for MDR cancer therapy.
- The mechanism involves lysosomal rupture induced by self-assembled PDI-AAs, leading to cancer cell death.
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Lysosomal Hydrolases
Cancer Cell Migration through Invadopodia
Site-Targeted Drug Delivery Systems: Polymeric Carriers

